Filgrastim biosimilar (PT Kalbe)

非格司亭生物类似药 (PT Kalbe)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (PT Kalbe)
Drug Alias Namerh G CSF (Kalbe Farma)非格司亭生物仿制药 (PT Kalbe)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/08/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKalbe Farma
China Registration ClassN/A

Develop Information

Active CompaniesKalbe Farma
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A